Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055507
Filed
Sep 10, 2021
Trade date
Aug 2-31, 2021
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $938.1. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2021Common StockPPurchaseAcquired+15$3.34+$50.15,768,844Direct
Aug 3, 2021Common StockPPurchaseAcquired+15$3.17+$47.555,768,859Direct
Aug 4, 2021Common StockPPurchaseAcquired+15$3.18+$47.75,768,874Direct
Aug 5, 2021Common StockPPurchaseAcquired+15$3.11+$46.655,768,889Direct
Aug 6, 2021Common StockPPurchaseAcquired+15$3.01+$45.155,768,904Direct
Aug 9, 2021Common StockPPurchaseAcquired+15$2.93+$43.955,768,919Direct
Aug 10, 2021Common StockPPurchaseAcquired+15$2.96+$44.45,768,934Direct
Aug 11, 2021Common StockPPurchaseAcquired+15$2.98+$44.75,768,949Direct
Aug 13, 2021Common StockPPurchaseAcquired+15$2.92+$43.85,768,964Direct
Aug 16, 2021Common StockPPurchaseAcquired+15$2.92+$43.85,768,979Direct
Aug 17, 2021Common StockPPurchaseAcquired+15$3.05+$45.755,768,994Direct
Aug 18, 2021Common StockPPurchaseAcquired+15$2.97+$44.555,769,009Direct
Aug 19, 2021Common StockPPurchaseAcquired+15$3.02+$45.35,769,024Direct
Aug 20, 2021Common StockPPurchaseAcquired+15$2.96+$44.45,769,039Direct
Aug 23, 2021Common StockPPurchaseAcquired+15$2.87+$43.055,769,054Direct
Aug 24, 2021Common StockPPurchaseAcquired+15$2.89+$43.355,769,069Direct
Aug 25, 2021Common StockPPurchaseAcquired+15$2.79+$41.855,769,084Direct
Aug 26, 2021Common StockPPurchaseAcquired+15$2.82+$42.35,769,099Direct
Aug 27, 2021Common StockPPurchaseAcquired+15$2.84+$42.65,769,114Direct
Aug 30, 2021Common StockPPurchaseAcquired+15$2.88+$43.25,769,129Direct
Aug 31, 2021Common StockPPurchaseAcquired+15$2.93+$43.955,769,144Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)